Search

For research investors, 2006 was the year that the European train finally started to leave the station. The new year will tell whether it’s going anywhere worth visiting.

The US federal spending on R&D continues its skyward progression.

IBM has teamed up with seven universities in the USA, in a deal that might smooth over some conflicts.

Ireland’s new Biomedical Diagnostics Institute was launched last week as the focus for industrial-clinical-academic research collaborations.

The UK is setting up a national network to carry out clinical trials of paediatric medicines, filling the gap left by pharmaceutical companies which usually test drugs only on adults.

Seven partners have teamed up with €2.4 million in EU backing to develop a vaccine against Alzheimer’s disease.

Transport | Aviation | Energy | Airbus | United Kingdom

A conference in Brussels separates the fact from myth in technology transfer.

For European tech start-ups, 2006 was the year that the traffic lights for money switched from red to yellow. Yet to be seen is whether they finally go green next year.

Pharminox Ltd, a private oncology R&D company backed by IP Group, is to carry out joint research into novel small molecule chemotherapeutics with Schering-Plough.

Galapagos NV is bolstering its ability to select drug targets and compounds by acquiring Inpharmatica Ltd in an all-share transaction that values the UK bioinformatics company at €12.5 million.